US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Direxion Daily MSCI South Korea Bull 3x Shares

84.23

-0.4300-0.51%

Pre-market: 82.24-1.9900-2.36%06:43 EDT

Volume:156.47K

Turnover:13.36M

Market Cap:158.35M

PE:- -

High:87.03

Open:86.87

Low:84.03

Close:84.66

Loading ...

Overview Company News Filings

KORU Medical Systems Names Adam Kalbermatten as Chief Commercial Officer

MT Newswires Live

South Korea Elects Lee President, Capping Six Months of Chaos

KORU Medical Systems Reports Record Growth and Optimism

KORU Medical Systems Is Maintained at Neutral by Piper Sandler

KORU Medical Systems Q1 Sales $9.63M Beat $8.87M Estimate

KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025

KORU Medical’s CCO Resigns, Interim Leader Appointed

KORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutions

Simply Wall St.

KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ...

KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025

KORU Medical Systems' Shares Fall After Downgrade From Piper Sandler

MT Newswires Live

Piper Sandler Downgrades KORU Medical Systems to Neutral From Overweight, $4.50 Price Target

MT Newswires Live

KORU Medical Systems Cut to Neutral From Overweight by Piper Sandler

KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology

KORU Medical Systems Is Maintained at Buy by Craig-Hallum

South Korean President Yoon Arrested Over Martial Law Fiasco

Press Release: KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KORU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KORU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KORU\",,,,,undefined,":{"symbol":"KORU","market":"US","secType":"STK","nameCN":"Direxion Daily MSCI South Korea Bull 3x Shares","latestPrice":84.23,"timestamp":1752609600000,"preClose":84.66,"halted":0,"volume":156466,"hourTrading":{"tag":"盘前","latestPrice":82.24,"preClose":84.23,"latestTime":"06:43 EDT","volume":225,"amount":18539.547749999998,"timestamp":1752662608335},"delay":0,"floatShares":1879924,"shares":1879924,"eps":0,"marketStatus":"Pre-Mkt","change":-0.43,"latestTime":"07-16 07:04:06 EDT","open":86.87,"high":87.0299,"low":84.03,"amount":13362179.97107,"amplitude":0.035435,"askPrice":83.05,"askSize":60,"bidPrice":82.25,"bidSize":2,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1752672600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":84.23,"sharesOutstanding":1879924.1,"nav":84.709,"aum":159246036.6,"dividendRate":0.012466,"bidAskSpread":0.001114,"preHourTrading":{"tag":"盘前","latestPrice":82.24,"preClose":84.23,"latestTime":"06:43 EDT","volume":225,"amount":18539.547749999998,"timestamp":1752662608335},"postHourTrading":{"tag":"盘后","latestPrice":84.23,"preClose":84.23,"latestTime":"19:47 EDT","volume":8633,"amount":725348.3516,"timestamp":1752623248792},"volumeRatio":0.963814909698122,"impliedVol":0.73,"impliedVolPercentile":0.6331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KORU\",,,,,undefined,":{"symbol":"KORU","floatShares":1879924,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.963814909698122,"shares":1879924,"dividePrice":1.05,"high":87.0299,"amplitude":0.035435,"preClose":84.66,"low":84.03,"week52Low":27.16,"pbRate":"--","week52High":91.9,"institutionHeld":0,"latestPrice":84.23,"committee":-0.935484,"eps":0,"divideRate":0.012466,"volume":156466,"delay":0,"ttmEps":0,"open":86.87,"prevYearClose":34.5,"prevWeekClose":82.51,"prevMonthClose":80.86,"prevQuarterClose":80.86,"fiveDayClose":81,"twentyDayClose":65.27,"sixtyDayClose":36.41},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KORU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549550825","title":"KORU Medical Systems Names Adam Kalbermatten as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2549550825","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549550825?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:15","pubTimestamp":1751919349,"startTime":"0","endTime":"0","summary":"KORU Medical Systems (KRMD) said Monday it named Adam Kalbermatten as chief commercial officer, starting July 28.Kalbermatten joins the company from Becton Dickinson (BDX), where he was most recently vice president and general manager, advanced drug delivery systems.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0985320562.USD","KORU","LU0433182093.SGD","LU0130103400.USD","LU1854104046.USD","BK4082","LU1489326972.SGD","LU0006061336.USD","LU1571399168.USD","LU1059921491.USD","LU1201861165.SGD","BK4585","LU1150488218.USD","LU0266013472.USD","LU0289739343.SGD","BDX","LU0511384066.AUD","LU0878866978.SGD","LU0289961442.SGD","LU1894683264.USD","LU0985489474.SGD","LU0648000940.SGD","LU1854103824.USD","LU0477156797.USD","LU1150488135.SGD","BK7067","LU0068578508.USD","BK4588","LU0130518102.USD","LU1894683348.USD","BK4504","IE00BFXG1179.USD","KRMD","BDX.AU"],"gpt_icon":0},{"id":"1157846627","title":"South Korea Elects Lee President, Capping Six Months of Chaos","url":"https://stock-news.laohu8.com/highlight/detail?id=1157846627","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157846627?lang=en_us&edition=fundamental","pubTime":"2025-06-04 08:00","pubTimestamp":1748995200,"startTime":"0","endTime":"0","summary":"South Korea’s opposition candidate Lee Jae-myung was elected president in a race that was largely a verdict on ousted leader Yoon Suk Yeol’s botched attempt to revive martial law after decades of demo","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-06-03/south-korea-s-lee-holds-clear-lead-in-election-exit-poll-shows?srnd=homepage-asia","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["EWY","FLKR","KB","KPOP","KORU","CPNG","KT","PKX","GRVY","KEP","LPL","DDI","SKM","MKOR","KF","SHG"],"gpt_icon":0},{"id":"2535734163","title":"KORU Medical Systems Reports Record Growth and Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2535734163","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535734163?lang=en_us&edition=fundamental","pubTime":"2025-05-13 08:14","pubTimestamp":1747095284,"startTime":"0","endTime":"0","summary":"Repro-Med Systems, Inc. (($KRMD)) has held its Q1 earnings call. Read on for the main highlights of the call. KORU Medical Systems’ Earnings Call H...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/koru-medical-systems-reports-record-growth-and-optimism?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/koru-medical-systems-reports-record-growth-and-optimism?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KORU"],"gpt_icon":0},{"id":"2534151888","title":"KORU Medical Systems Is Maintained at Neutral by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2534151888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534151888?lang=en_us&edition=fundamental","pubTime":"2025-05-09 00:44","pubTimestamp":1746722640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2025 12:44 ET (16:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","KRMD"],"gpt_icon":0},{"id":"2533649799","title":"KORU Medical Systems Q1 Sales $9.63M Beat $8.87M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533649799","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533649799?lang=en_us&edition=fundamental","pubTime":"2025-05-08 04:43","pubTimestamp":1746650592,"startTime":"0","endTime":"0","summary":"KORU Medical Systems (NASDAQ:KRMD) reported quarterly sales of $9.63 million which beat the analyst consensus estimate of $8.87 million by 8.62 percent.  This is a 17.53 percent increase over sales of $8.20 million the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45268281/koru-medical-systems-q1-sales-9-63m-beat-8-87m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","KRMD"],"gpt_icon":0},{"id":"2528320873","title":"KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528320873","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528320873?lang=en_us&edition=fundamental","pubTime":"2025-04-17 04:05","pubTimestamp":1744833900,"startTime":"0","endTime":"0","summary":"MAHWAH, N.J., April 16, 2025----KORU Medical Systems, Inc.  , a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2025 financial results on Wednesday, May 7, 2025. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-report-first-200500715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","KORU","KRMD"],"gpt_icon":0},{"id":"2525797000","title":"KORU Medical’s CCO Resigns, Interim Leader Appointed","url":"https://stock-news.laohu8.com/highlight/detail?id=2525797000","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525797000?lang=en_us&edition=fundamental","pubTime":"2025-04-08 04:31","pubTimestamp":1744057868,"startTime":"0","endTime":"0","summary":"REPRO-MED Systems ( ($KRMD) ) has shared an announcement. On April 3, 2025, Kenneth Miller resigned as Chief Commercial Officer of KORU Medical Sys...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/koru-medicals-cco-resigns-interim-leader-appointed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/koru-medicals-cco-resigns-interim-leader-appointed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2357125470.USD","CCO","LU2249611893.SGD","LU2294711713.HKD","LU0823414551.USD","KORU","BK4009","LU0823414478.USD","LU2506951792.HKD"],"gpt_icon":0},{"id":"2520437974","title":"KORU Medical Systems, Inc.'s (NASDAQ:KRMD) market cap dropped US$17m last week; individual investors who hold 43% were hit as were institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437974","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437974?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:28","pubTimestamp":1742466499,"startTime":"0","endTime":"0","summary":"The considerable ownership by retail investors in KORU Medical Systems indicates that they collectively have a greater say in management and business strategy. A total of 12 investors have a majority stake in the company with 50% ownership. Institutional ownership in KORU Medical Systems is 28%. If you want to know who really controls KORU Medical Systems, Inc. , then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are retail investors with 43% ownership. That is, the group stands to benefit the most if the stock rises .While the holdings of retail investors took a hit after last week’s 11% price drop, institutions with their 28% holdings also suffered.Let's take a closer look to see what the different types of shareholders can tell us about KORU Medical Systems.Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-inc-nasdaq-102819801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","IE00BGHQF748.EUR","TQQQ","BK4588","IE00B3QW5Z07.USD","BK4585","QID","MNQmain","NQmain","IE00B64PRP62.GBP","LU2095319765.USD","KORU","KRMD","NVIW.SI","USAW.SI","BK4112","USJW.SI","IE00BKPKM429.USD","SQQQ","QLD","BK4082","LU2210149790.SGD","TSYW.SI","NDAQ",".IXIC","LU2210150020.SGD"],"gpt_icon":1},{"id":"2519005269","title":"KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2519005269","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519005269?lang=en_us&edition=fundamental","pubTime":"2025-03-13 15:08","pubTimestamp":1741849695,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.KORU Medical Systems Inc  achieved record-setting revenues in the fourth quarter, with a 23% increase, and full-year revenues grew by 18%.The company expanded its gross margins, achieving a record-setting gross profit for the full year 2024.The company added four new collaborations to its novel therapies pipeline in 2024, with two more announced in early 2025.KORU Medical Systems Inc  maintained a strong cash position, ending the year with a cash balance of $9.6 million, exceeding expectations.The novel therapies segment is subject to revenue lumpiness, which could impact overall financial performance.The company faces potential challenges from tariffs, although the impact is expected to be minimal.A: Linda Tharby, CEO: The team used AI to identify growth opportunities, signed new agreements, and implemented a price increase. While 20% growth may not be consistent, we are confident in 10","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-inc-krmd-070815140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KRMD","KORU"],"gpt_icon":0},{"id":"2512432346","title":"KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512432346","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512432346?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:05","pubTimestamp":1739999100,"startTime":"0","endTime":"0","summary":"MAHWAH, N.J., February 19, 2025----KORU Medical Systems, Inc.  , a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report fourth quarter and full year 2024 financial results on Wednesday, March 12, 2025. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-report-fourth-210500314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KORU","BK4082","KRMD"],"gpt_icon":0},{"id":"2511619425","title":"KORU Medical Systems' Shares Fall After Downgrade From Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2511619425","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511619425?lang=en_us&edition=fundamental","pubTime":"2025-02-15 03:31","pubTimestamp":1739561492,"startTime":"0","endTime":"0","summary":"KORU Medical Systems  shares were down nearly 7% in recent Friday trading after Piper Sandler downgraded the company's stock to neutral from overweight, with a $4.50 price target.The company's trading volume stood at over 103,000 shares against a daily average of about 153,000.Price: 4.43, Change: -0.32, Percent Change: -6.67","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KORU","KRMD"],"gpt_icon":0},{"id":"2511662258","title":"Piper Sandler Downgrades KORU Medical Systems to Neutral From Overweight, $4.50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2511662258","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511662258?lang=en_us&edition=fundamental","pubTime":"2025-02-14 20:41","pubTimestamp":1739536878,"startTime":"0","endTime":"0","summary":"KORU Medical Systems (KRMD) has an average rating of Buy and mean price target of $5.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KRMD","KORU"],"gpt_icon":0},{"id":"2511766762","title":"KORU Medical Systems Cut to Neutral From Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2511766762","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511766762?lang=en_us&edition=fundamental","pubTime":"2025-02-14 20:40","pubTimestamp":1739536800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 14, 2025 07:40 ET (12:40 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","KRMD"],"gpt_icon":0},{"id":"2509784871","title":"KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2509784871","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509784871?lang=en_us&edition=fundamental","pubTime":"2025-02-07 05:05","pubTimestamp":1738875900,"startTime":"0","endTime":"0","summary":"MAHWAH, N.J., February 06, 2025----KORU Medical Systems, Inc.  , a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin  therapy infusion system for use with a commercialized drug therapy.Additionally, the project will include a close collaboration with SCHOTT Pharma and is expected to be the first of multiple joint projects with SCHOTT, allowing KORU Medical to develop a platform infusion system that can integrate with both a vial and prefilled syringe. The innovative system will be developed using KORU Medical’s infusion technology along with SCHOTT TOPPAC prefillable polymer syringes .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-announces-agreement-210500497.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","KRMD","BK4195","PFS","KORU","BK4082"],"gpt_icon":0},{"id":"2507560370","title":"KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology","url":"https://stock-news.laohu8.com/highlight/detail?id=2507560370","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507560370?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:05","pubTimestamp":1738271100,"startTime":"0","endTime":"0","summary":"MAHWAH, N.J., January 30, 2025----KORU Medical Systems  , a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced a collaboration with a global pharmaceutical manufacturer on a Phase III clinical trial for an expanded indication of a commercialized drug therapy. The expanded indication is intended to treat a rare renal disorder in a population of approximately 30,000 patients with a projected 300,000 annual infusions.This announcement highlights an additional collaboration between KORU Medical and its partners in the development of novel therapies and enhanced drug delivery experiences for patients living with rare conditions. The Phase III trial aims to assess the safety, efficacy, and performance of the drug to treat patients with complications from kidney transplants.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/koru-medical-systems-announces-phase-210500904.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KRMD","BK4134","KORU","BK4082","III"],"gpt_icon":0},{"id":"2504192005","title":"KORU Medical Systems Is Maintained at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2504192005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504192005?lang=en_us&edition=fundamental","pubTime":"2025-01-18 02:01","pubTimestamp":1737136860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KRMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 17, 2025 13:01 ET (18:01 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","KRMD"],"gpt_icon":0},{"id":"1164518568","title":"South Korean President Yoon Arrested Over Martial Law Fiasco","url":"https://stock-news.laohu8.com/highlight/detail?id=1164518568","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164518568?lang=en_us&edition=fundamental","pubTime":"2025-01-15 09:47","pubTimestamp":1736905646,"startTime":"0","endTime":"0","summary":"South Korean investigators arrested President Yoon Suk Yeol on Wednesday after launching a pre-dawn operation to bring the impeached leader in for questioning over his short-lived martial law declaration.The Corruption Investigation Office for High-ranking Officials had been looking to bring Yoon into custody after the president repeatedly defied summons to appear for questioning. CIO investigators abandoned their first attempt to arrest him on Jan. 3 after a nearly six-hour standoff due to resi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bloomberg.com/news/articles/2025-01-15/south-korean-investigators-arrest-yoon-at-second-attempt","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1584095487587","symbols":["GRVY","SHG","KT","CPNG","SKM","EWY","KF","MKOR","FLKR","DDI","KPOP","KORU","KB","PKX","LPL","KEP"],"gpt_icon":1},{"id":"2503309630","title":"Press Release: KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309630","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309630?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter. KORU Medical Systems  , a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced preliminary unaudited results for the fourth quarter and full year ended December 31, 2024.Preliminary, unaudited fourth quarter 2024 net revenues expected to be. $8.9 million, representing growth of 23% over the prior year period. Preliminary, unaudited full year 2024 net revenues expected to be $33.7. $0.8 million for the fourth quarter and full year cash burn of $1.9. KORU plans to release its fourth quarter and full year 2024 financial results in early March 2025. The quarterly and annual preliminary revenue figures included in this press release are subject to adjustment following the comp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KORU","KRMD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KORU\",params:#limit:5,,,undefined,":[{"date":"2025-06-24","symbol":"KORU","amount":0.09143,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"Direxion Daily MSCI South Korea Bull 3x Shares","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"KORU","amount":0.05277,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"Direxion Daily South Korea Bull","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"market":"US","date":"2025-02-10","symbol":"KORU","defaultRemindTime":1739197800000,"type":"split","dateTimestamp":1739163600000,"forFactor":10,"toFactor":1,"ratio":10},{"date":"2024-12-23","symbol":"KORU","amount":0.07536,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Direxion Daily South Korea Bull","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-31"},{"date":"2024-09-24","symbol":"KORU","amount":0.0154,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-24","defaultRemindTime":1727184600000,"name":"Direxion Daily South Korea Bull","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-01","payableDate":"2024-09-24","currency":"USD","dateTimestamp":1727150400000,"payDate":"2024-10-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KORU\",market:\"US\",,,undefined,":[{"executeDate":"2018-03-20","recordDate":"2018-03-21","paymentDate":"2018-03-27","value":0.20702,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.13844,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.02739,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-31","value":0.18996,"currency":"USD"},{"executeDate":"2020-12-22","recordDate":"2020-12-23","paymentDate":"2020-12-30","value":0.00312,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KORU\",market:\"US\",delay:false,,,undefined,":{}}}